These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia. Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810 [TBL] [Abstract][Full Text] [Related]
3. Oxidative stress in human aging and mitochondrial disease-consequences of defective mitochondrial respiration and impaired antioxidant enzyme system. Wei YH; Lu CY; Wei CY; Ma YS; Lee HC Chin J Physiol; 2001 Mar; 44(1):1-11. PubMed ID: 11403514 [TBL] [Abstract][Full Text] [Related]
5. Perspectives of drug-based neuroprotection targeting mitochondria. Procaccio V; Bris C; Chao de la Barca JM; Oca F; Chevrollier A; Amati-Bonneau P; Bonneau D; Reynier P Rev Neurol (Paris); 2014 May; 170(5):390-400. PubMed ID: 24792485 [TBL] [Abstract][Full Text] [Related]
6. Insights into the role of oxidative stress in the pathology of Friedreich ataxia using peroxidation resistant polyunsaturated fatty acids. Cotticelli MG; Crabbe AM; Wilson RB; Shchepinov MS Redox Biol; 2013; 1(1):398-404. PubMed ID: 25499576 [TBL] [Abstract][Full Text] [Related]
7. Movement disorders in mitochondrial diseases. Tranchant C; Anheim M Rev Neurol (Paris); 2016; 172(8-9):524-529. PubMed ID: 27476418 [TBL] [Abstract][Full Text] [Related]
8. Mitochondrial dysfunction, oxidative stress and neurodegeneration. Mancuso M; Coppede F; Migliore L; Siciliano G; Murri L J Alzheimers Dis; 2006 Sep; 10(1):59-73. PubMed ID: 16988483 [TBL] [Abstract][Full Text] [Related]
11. The expanding clinical spectrum of mitochondrial diseases. De Vivo DC Brain Dev; 1993; 15(1):1-22. PubMed ID: 8338207 [TBL] [Abstract][Full Text] [Related]
12. Mitochondrial Gymnastics in Retinal Cells: A Resilience Mechanism Against Oxidative Stress and Neurodegeneration. Mirra S; Marfany G Adv Exp Med Biol; 2019; 1185():513-517. PubMed ID: 31884663 [TBL] [Abstract][Full Text] [Related]
16. The therapeutic potential of a calorie-restricted ketogenic diet for the management of Leber hereditary optic neuropathy. Storoni M; Robert MP; Plant GT Nutr Neurosci; 2019 Mar; 22(3):156-164. PubMed ID: 28994349 [TBL] [Abstract][Full Text] [Related]
17. Use of mitochondrial antioxidant defenses for rescue of cells with a Leber hereditary optic neuropathy-causing mutation. Qi X; Sun L; Hauswirth WW; Lewin AS; Guy J Arch Ophthalmol; 2007 Feb; 125(2):268-72. PubMed ID: 17296905 [TBL] [Abstract][Full Text] [Related]
18. FGF21 in ataxia patients with spinocerebellar atrophy and mitochondrial disease. Su SL; Wang WF; Wu SL; Wu HM; Chang JC; Huang CS; Cheng WL; Soong BW; Lee YC; Li JY; Kuo SJ; Chen M; Huang CN; Liu CS Clin Chim Acta; 2012 Dec; 414():225-7. PubMed ID: 23031666 [TBL] [Abstract][Full Text] [Related]
19. Optic neuropathy induced by reductions in mitochondrial superoxide dismutase. Qi X; Lewin AS; Hauswirth WW; Guy J Invest Ophthalmol Vis Sci; 2003 Mar; 44(3):1088-96. PubMed ID: 12601034 [TBL] [Abstract][Full Text] [Related]